Ellen Coleman outlines the highlights of a recent webinar on ensuring that patient advocacy is a key element of a market access strategy.
Ellen Coleman
Advertisement
Ellen Coleman (ecoleman@mkanda.com) is President and Chief Executive Officer, MK&A.
Articles by Ellen Coleman
Advertisement
Latest Updated Articles
- Patient Advocacy: an Overlooked Strategy for Achieving Equitable Market Success?
Published: May 14th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
3
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
